Skip to main
CTRE

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 67%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

CareTrust REIT has significantly expanded its structured finance portfolio from $15 million in early 2022 to $871 million, which strengthens operator relationships and diversifies revenue sources. The company's core portfolio is exhibiting a recovery, supported by strong corporate guarantees on leases, while the operator environment has stabilized, enhancing prospects for capital deployment. The performance of similar healthcare-focused REITs, exhibiting average same-store NOI growth of 22%, indicates a robust market landscape that suggests CareTrust REIT is well-positioned for continued growth and profitability.

Bears say

CareTrust REIT is facing a negative outlook due to a projected decline in cash collections by approximately 5%, attributed to a lower growth outlook and potential increases in competition driving property prices higher, which may adversely affect profitability. The anticipated slowdown in investment activity could reduce total investments to around $1 billion, coupled with the concern that the CA 525 bill may negatively impact operators' profitability and exert pressure on CareTrust's rent revenues. Furthermore, potential new tenant issues and tightening capital market conditions could lead to decreased liquidity, negatively affecting cash investments and overall valuations in the healthcare real estate sector.

CareTrust REIT (CTRE) has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 67% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 9 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $43.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $43.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.